Basic information
Biomarker: PR
Histology type: endometrial carcinoma
Cohort characteristics
Country: Netherlands
Region: Nijmegen
Followed up time :
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
378 | EC |
Sample information
Conclusion: In conclusion to improve correct preoperative diagnosis in EC, we recommend use of a panel of at least two easily accessible immunohistochemical biomarkers (PR and p53), only in grade 2 ECs.
Sample type : tissue
Sample method: immunohistochemistry
Expression pattern : PR+p53
Expression elevation: The staining index (0-9) was obtained by the product of intensity, graded from 0 (no staining), 1 (weak staining), 2 (moderate staining) to 3 (strong staining), and area of tumor with this staining intensity, graded from 0 (no positive tumor cells), 1 (1-10% positive tumor cells), 2 (11-50% positive tumor cells) to 3 (>50% positive tumor cells).
Disease information
Related information
Funtion Uniprot: The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Depending on the isoform, progesterone receptor functions as transcriptional activator or repressor.3 PublicationsCurated Isoform A Ligand-dependent transdominant repressor of steroid hormone receptor transcriptional activity including repression of its isoform B, MR and ER. Transrepressional activity may involve recruitment of corepressor NCOR2.3 Publications2 Publications Isoform B Transcriptional activator of several progesteron-dependent promoters in a variety of cell types. Involved in activation of SRC-dependent MAPK signaling on hormone stimulation.1 Publication Isoform 4 Increases mitochondrial membrane potential and cellular respiration upon stimulation by progesterone.
UniProt ID: P06401
UniProt Link: https://www.uniprot.org/uniprotkb/P06401/entry
Biological function from UniProt: #Transcription #Transcription regulation
Molecular function from UniProt:
Tissue specificity from UniProt: In reproductive tissues the expression of isoform A and isoform B varies as a consequence of developmental and hormonal status. Isoform A and isoform B are expressed in comparable levels in uterine glandular epithelium during the proliferative phase of the menstrual cycle. Expression of isoform B but not of isoform A persists in the glands during mid-secretory phase. In the stroma, isoform A is the predominant form throughout the cycle. Heterogeneous isoform expression between the glands of the endometrium basalis and functionalis is implying region-specific responses to hormonal stimuli
Subcellular UniProt: #Cytoplasm #Membrane #Mitochondrion #Mitochondrion outer membrane #Nucleus
Alternative name from UniProt:
Recommended name: Progesterone receptor
Gene name from HGNC: PGR (NR3C3, PR)
HPA class: Cancer-related genes FDA approved drug targets Nuclear receptors Transcription factors Transporters
AlphaFold DB: P06401
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/P06401
HPA link: https://www.proteinatlas.org/ENSG00000082175-PGR
Tissue specificity RNA from HPA: Group enriched (cervix, endometrium, fallopian tube, smooth muscle)
Tissue expression from HPA: Selective nuclear expression in female reproductive system and smooth muscle.
Single cell type specificity Cell type enhanced (Endometrial stromal cells, Endometrial ciliated cells, Glandular and luminal cells, Early spermatids, Late spermatids)
Immune cell specificity: Not detected in immune cells
Cancer prognostic summary HPA Prognostic marker in endometrial cancer (favorable)
Pathology link: https://www.proteinatlas.org/ENSG00000082175-PGR/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000082175-PGR/pathology/endometrial+cancer
OMIM: 607311
OMIM link2: https://www.omim.org/entry/607311
HGNC ID: HGNC:8910
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:8910